Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Harith Rajagopalan
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
metabolic diseases
treatments for type 2 diabetes |
| gptkbp:foundedYear |
2010
|
| gptkbp:founder |
Harith Rajagopalan
Om Ganda |
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fractyl Laboratories
|
| gptkbp:industry |
gptkb:biotechnology
medical devices |
| gptkbp:notableProduct |
Revita DMR System
|
| gptkbp:openToPublic |
private
|
| gptkbp:website |
https://www.fractyl.com/
|
| gptkbp:bfsParent |
gptkb:Clive_Meanwell
|
| gptkbp:bfsLayer |
7
|